冠心病心绞痛中医治疗研究进展及用药分析

Research Progress and Drug Analysis of Traditional Chinese Medicine Treatment of Coronary Heart Disease Angina Pectoris

摘要: 冠心病是以冠状动脉粥样硬化为病理基础的一类心血管疾病，受冠心病心绞痛而困扰患者人群巨大，其在心脑血管疾病发生中发挥不容忽视的诱发作用，威胁到患者身心健康，其治疗成本也加重了社会和家庭经济负担。本病在中医学中多属于“胸痹”范畴。而中医认为动脉粥样硬化的发生过程与痰浊、血瘀、气滞等密切相关。临床症状主要有胸闷、心悸、出汗等情况。目前西药治疗面临着较大弊端，主要体现在不良反应较明显，同时还有明显的长期耐药性。为改善该疗法负面性，可充分发挥中医药治疗特有优势，效果明显，且不良反应较小。

Abstract: Coronary heart disease (CHD) is a kind of cardiovascular disease based on coronary atherosclerosis. It is a huge population of patients with coronary heart disease and angina pectoris. It plays an important role in the occurrence of cardiovascular and cerebrovascular diseases, threatening the physical and mental health of patients. The cost of treatment also increases the social and family economic burden. This disease belongs to the category of “chest impediment” in traditional Chinese medicine. Traditional Chinese medicine believes that the occurrence of atherosclerosis is closely related to phlegm, blood stasis and qi stagnation. The main clinical symptoms are chest tightness, palpitations, sweating and so on. At present, western medicine treatment is facing great disadvantages, mainly reflected in the obvious adverse reactions, as well as obvious long-term drug resistance. In order to improve the negative side of the therapy, it can give full play to the unique advantages of traditional Chinese medicine treatment, the effect is obvious, and the adverse reactions are small.